Skip to main content

Advertisement

SpringerLink
Log in

The Toxicologist and Delirium: Flumazenil as a Diagnostic and Therapeutic Tool for Delirium During the Course of Alcohol Withdrawal

  • The Poison Pen
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Moore PW, Donovan JW, Burkhart KK, Waskin JA, Hieger MA, Adkins AR, Wert Y, Haggerty DA and Rasimas JJ.Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center. J Med Toxicol 2014.

  2. Lat I, McMillian W, Taylor S, Janzen JM, Papadopoulos S, Korth L, Ehtisham A, Nold J, Agarwal S, Azocar R, Burke P (2009) The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients. Crit Care Med 37(6):1898–905

    Article  PubMed  Google Scholar 

  3. McPherson JA, Wagner CE, Boehm LM, Hall JD, Johnson DC, Miller LR, Burns KM, Thompson JL, Shintani AK, Ely EW, Pandharipande PP (2014) Delirium in the cardiovascular intensive care unit: exploring modifiable risk factors. Crit Care Med 41(2):405–13

    Article  Google Scholar 

  4. Pandharipande P, Shintani A, Peterson J, Pun BT, Wilkinson GR, Dittus RS, Bernard GR, Ely EW (2006) Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 104(1):21–6

    Article  CAS  PubMed  Google Scholar 

  5. Maldonado JR (2008) Delirium in the acute care setting: characteristics, diagnosis and treatment. Crit Care Clin 24(4):657–722, vii

    Article  CAS  PubMed  Google Scholar 

  6. Ferguson JA, Suelzer CJ, Eckert GJ, Zhou XH, Dittus RS (1996) Risk factors for delirium tremens development. J Gen Intern Med 11(7):410–4

    Article  CAS  PubMed  Google Scholar 

  7. Nelson LS (2014) Alcohol withdrawal and flumazenil: Not for the faint of heart. J Med Toxicol 10(2):123–5

    Article  PubMed  Google Scholar 

  8. Tetrault JM, O’Connor PG (2008) Substance abuse and withdrawal in the critical care setting. Crit Care Clin 24(4):767–88, viii

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank JJ Rasimas for contributing to this response.

Author information

Authors and Affiliations

  1. Penn State University College of Medicine, Hershey, PA, USA

    Philip W Moore & J Ward Donovan

  2. Virginia Commonwealth University, Richmond, VA, USA

    Michelle A Hieger

Authors
  1. Philip W Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle A Hieger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Ward Donovan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philip W Moore.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moore, P.W., Hieger, M.A. & Donovan, J.W. The Toxicologist and Delirium: Flumazenil as a Diagnostic and Therapeutic Tool for Delirium During the Course of Alcohol Withdrawal. J. Med. Toxicol. 10, 436–437 (2014). https://doi.org/10.1007/s13181-014-0434-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-014-0434-z

Keywords

Search

Navigation